ÂÜÀòÂÒÂ×

Andy Bevan is an experienced clinical research professional and chartered scientist with over 20 years in the CRO industry, specializing in managing large international Phase III – IV cardiovascular and metabolic studies, as well as studies in pediatric and rare disease populations. Previously, Andy held various roles at organizations such as PPD, PRA International, and Evidera, culminating in positions like Executive Director at Evidera and Thermo Fisher Scientific. At present, Andy serves as an Executive Oversight Director for Neuroscience, leading teams and driving strategic initiatives within the therapeutic area.